Rare Tumors

该期刊要求在投稿过程中列出每位作者的贡献，并在致谢部分之后加入“作者贡献”标题，该信息将在校对阶段显示。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

该期刊鼓励作者在符合伦理和法律要求的前提下，将研究数据存入公共数据仓库、提供数据可用性声明并在论文中引用数据；若无法共享数据，需在声明中说明原因。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

该期刊要求在指定标题下提供伦理批准声明；若无需伦理批准须明确说明，涉及人类参与者、数据或组织的研究必须注明伦理委员会或机构审查委员会的批准或豁免，并提供委员会全称、所属机构及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

该期刊的稿件内容根据知识共享许可协议进行许可。 模型中文摘要

Manuscript content on this site is licensed under Creative Commons Licenses

该期刊为开放获取期刊，接受的文章在出版后立即免费在线发布，采用知识共享许可并永久在线保存；稿件被接受后需支付2400美元的文章处理费，投稿本身不收费。 模型中文摘要

Rare Tumors is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the funder, insti…

该期刊采用单盲同行评审，审稿人与编辑互动且不公开审稿信息；稿件先经初步评估，不符合要求将被退回修改，超出范围或不合适的稿件可能未经同行评审即被拒稿。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…

该期刊和Sage严肃对待版权侵权、抄袭及其他违反出版最佳实践的行为，并提供了完整的抄袭政策供查阅。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊不接受已在预印本服务器上发布过的稿件。 模型中文摘要

The journal does not accept submissions of manuscripts that have been posted on preprint servers.

该期刊遵循ICMJE要求，临床试验须在首个受试者入组时或之前在WHO认可的公共试验注册机构注册，作为发表考虑的条件，且注册名称、网址和注册号须列入摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.